Data / Form D filings / Rapid Pathogen Screening Inc
Rapid Pathogen Screening Inc: Form D filings
Rapid Pathogen Screening Inc, a biotechnology company in Sarasota, FL, filed 7 Form D notices with the SEC between 2010 and 2013. The latest, on July 22, 2013, reports $6.3 million sold of a $10 million offering to 1 investor.
Find out what Rapid Pathogen Screening Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7227 DELAINEY COURT, Sarasota, FL, 34240
- Phone
- (941) 556-1866
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1338026
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2013 | New notice | $10,000,000 | $6,250,000 | $3,750,000 | 1 | Jul 17, 2013 | sec.gov |
| Jul 22, 2013 | Amendment | $15,000,000 | $2,284,125 | $12,715,875 | 25 | Oct 8, 2012 | sec.gov |
| Oct 22, 2012 | New notice | $15,000,000 | $30,000 | $14,970,000 | 1 | Oct 8, 2012 | sec.gov |
| Oct 10, 2012 | Amendment | $22,000,000 | $6,790,950 | $15,209,050 | 57 | Sep 7, 2010 | sec.gov |
| Dec 2, 2011 | Amendment | $22,000,000 | $5,180,000 | $16,820,000 | 36 | Sep 7, 2010 | sec.gov |
| Sep 14, 2010 | New notice | $22,000,000 | $0 | $22,000,000 | 1 | Sep 7, 2010 | sec.gov |
| Feb 9, 2010 | Amendment | $15,000,000 | $15,000,000 | $0 | 71 | Jan 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles T. Saldarini | Director | |
| Daniel Sambursky | Director | |
| Caroline T. Popper | Director | |
| Robert Sambursky | Executive Officer, Director | |
| Robert VanDine | Executive Officer, Director | |
| J. Scott Womble | Executive Officer | |
| Thomas Orsini | Director | |
| Jules Musinger | Director | |
| Stephen R. La Neve | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Jul 22, 2013 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rapid Pathogen Screening Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.